Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Conditions: Metastatic Breast Cancer; Advanced Breast Cancer; Quality of Life; Toxicity; Older Patients Interventions: Drug: CDK 4/6 inhibitors; Drug: Endocrine therapy Sponsors: Region Örebro County; University of Patras; University of Florence; Azienda USL Toscana Centro; Helsinki University Central Hospital; Institute for Medical Technology Assessment - the Netherlands; Security Labs Consulting Limited; Circular Economy Foundatio n; Universidad Nacional de Educación a Distancia; Hellenic Cooperative Oncology Group; University Hospital, Akershus; Uppsala County Council, Sweden; Hospital Clinic of Barcelona; Phaze Clinical Research & Pharma Consulting; Bröstcancerförbundet; Eunomia Ltd; University of Applied Sciences and Arts Northwestern Switzerland; CareAcross Ltd; Örebro University, Sweden Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Geriatrics | Hospitals | Netherlands Health | Research | Sweden Health | Switzerland Health | Toxicology